The Cancer

Don't Miss

Childhood Most cancers Survivors Face Lengthy-Time period Meningioma Danger

Researchers at UT Southwestern Medical Heart led a research revealed in JAMA Community Open which discovered that particular chemotherapies are related to an elevated long-term...

Professional Discusses FDA Approval of Chemo-Free Possibility for EGFR-Mutated Lung Most cancers

The FDA has accepted Rybrevant Faspro (amivantamab and hyaluronidase-lpuj) as the primary and solely subcutaneous, chemo-free therapy for sufferers with EGFR-mutated non-small cell lung most...

FDA Clears Protocol Replace for Tasquinimod in Myelofibrosis Trial

Lively Biotech has obtained optimistic suggestions from regulators on a protocol modification to its ongoing proof-of-concept scientific trial evaluating tasquinimod in sufferers with myelofibrosis, a...

Vital Information

Facts

Latest Articles

A risk-stratified strategy to colorectal most cancers prevention and analysis

Ait Ouakrim, D. et al. Tendencies in colorectal most cancers mortality in Europe: retrospective evaluation of the WHO mortality database. BMJ 351, h4970...

Former Wisconsin basketball participant Walt McGrory nonetheless combating most cancers

MADISON – Walt McGrory’s combat in opposition to most cancers continues.McGrory, who joined the Wisconsin males’s basketball program in 2017 and was a...

New Drug Boosts Survival in Relapsed Acute Myeloid Leukemia

Relapsed/refractory acute myeloid leukemia (AML), a so-called blood most cancers, has a particularly poor prognosis due to resistance to anti-cancer medicine and frailty...

Hot Topics